glp 1 drugs and pancreatitis GLP-1 carry small risk: MHRA The GLP-1 Agonists and Obesity:

10.1016/j.bbrc.2005.09.128 Biochem

Stability & Half-Life Data Plasma half-life: Approximately 30 minutes following systemic administration in rodent pharmacokinetic studies

It's a really promising candidate (see below), but while reading all the goodness about it in a minute, do not forget that derivatives not only have to be absorbed into the skin but also have to be converted to pure vitamin C (ascorbic acid or AA) and the efficacy of the conversion is often unknown

Human clinical trial data is extremely limited

These effects tend to be temporary and mild to moderate in severity, especially when doses are increased gradually

Pullulan is the next generation in encapsulation, derived from tapioca and processed with water